Editors' Pick Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033 Tran JQ, Rana J, Barkhof F, Melamed I, Gevorkyan H, Wattjes MP, de Jong R, Brosofsky K, Ray S, Xu L, et al., 27 Aug 2014 Accessed on 27 Aug 2014 from http://nn.neurology.org/content/1/2/e18.short. doi:10.1212/NXI.0000000000000018. CommentRecommendBookmarkWatch